Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo

被引:94
作者
Lassau, N
Koscielny, S
Opolon, P
De Baere, T
Peronneau, P
Leclere, J
Roche, A
机构
[1] Inst Gustave Roussy, Dept Med Imaging, Ultrasonog Unit, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Biostat, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
[4] CNRS LBHP ESA7057, Paris, France
关键词
angiogenesis; color Doppler ultrasonography; tumor; contrast agent;
D O I
10.1097/00004424-200101000-00007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
RATIONALE AND OBJECTIVES. TO evaluate contrast-enhanced color Doppler ultrasonography (CDUS) aimed at quantifying angiogenesis in vivo. METHODS. Eight colon tumors xenografted into mice were studied with CDUS both without and after injection of SHU 508A, The number of intratumor vessels and pedicles visualized with CDUS and the value of the acoustic intensity quantified by computer were compared with the evaluation of angiogenesis by study of digitized histological slides, RESULTS. SHU 508A increased the number of intratumor vessels and pedicles depicted by CDUS, which could also be quantified by acoustic intensity. The comparison of CDUS and digitized histological slide studies showed that the detection threshold after SHU 508A administration allowed visualization of small vessels (40 mum in diameter). The "hot spots" seen on histology were superimposable onto vessels seen with CDUS, Regions in which no vessels were detected by CDUS corresponded to regions in which vascularization was absent by histological analysis. CONCLUSION. Injection of SHU 508A significantly increased vessel detection with CDUS.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 17 条
[1]   Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion:: Preliminary experience [J].
Albrecht, T ;
Urbank, A ;
Mahler, M ;
Bauer, A ;
Doré, CJ ;
Blomley, MJK ;
Cosgrove, DO ;
Schlief, R .
RADIOLOGY, 1998, 207 (02) :339-347
[2]   Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: Early experience in seven patients with metastases [J].
Blomley, MJK ;
Albrecht, H ;
Cosgrove, PO ;
Jayaram, V ;
Eckersley, RJ ;
Patel, N ;
Taylor-Robinson, T ;
Bauer, A ;
Schlief, R .
RADIOLOGY, 1998, 209 (03) :862-866
[3]  
BUSTIN P, 1977, CANCER, V39, P2378
[4]   Contrast enhancing agents in ultrasonography: Clinical applications [J].
Campani, R ;
Calliada, F ;
Bottinelli, O ;
Bozzini, A ;
Sommaruga, MG ;
Draghi, F ;
Anguissola, R .
EUROPEAN JOURNAL OF RADIOLOGY, 1998, 27 :S161-S170
[5]   ANGIOGENESIS, NEOVASCULAR PROLIFERATION AND VASCULAR PATHOPHYSIOLOGY AS TARGETS FOR CANCER-THERAPY [J].
DENEKAMP, J .
BRITISH JOURNAL OF RADIOLOGY, 1993, 66 (783) :181-196
[6]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[7]   New perspectives in clinical oncology from angiogenesis research [J].
Folkman, J .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2534-2539
[8]   First experiences in using a new ultrasound mode and ultrasound contrast agent in the diagnosis of blunt renal trauma - A feasibility study in an animal model [J].
Hochmuth, A ;
Fleck, M ;
Hauff, P ;
Reinhardt, M ;
Kosmehl, H ;
Hilger, I ;
Dinkelborg, L ;
Kaiser, WA .
INVESTIGATIVE RADIOLOGY, 2000, 35 (03) :205-211
[9]   Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US - Early experience [J].
Huber, S ;
Helbich, T ;
Kettenbach, J ;
Dock, W ;
Zuna, I ;
Delorme, S .
RADIOLOGY, 1998, 208 (02) :485-489
[10]   INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED ANGIOGENESIS SUPPRESSES TUMOR-GROWTH INVIVO [J].
KIM, KJ ;
LI, B ;
WINER, J ;
ARMANINI, M ;
GILLETT, N ;
PHILLIPS, HS ;
FERRARA, N .
NATURE, 1993, 362 (6423) :841-844